Coffee intake was linked with colorectal cancer outcomes in observational studies
A pooled analysis linked coffee drinking with better survival and less recurrence. The abstract leaves the intake comparisons and follow-up periods unclear.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Among people with colorectal cancer, coffee consumption was associated with better survival and less recurrence in the pooled studies. These observational results do not show that coffee caused the differences. Because the abstract does not specify the reference intake behind its main estimates, it cannot support a clear comparison between particular drinking habits.
The abstract does not describe follow-up lengths, the main intake comparison or how studies accounted for other patient differences. Those gaps limit interpretation of the reported associations.
Related but distinct outcomes
The review examined overall survival, survival without cancer progression and recurrence. These describe different aspects of prognosis. It also assessed whether associations varied with daily coffee intake, coffee type and cancer stage.
Stage findings need context
The strongest reported overall-survival association involved stage III disease. The abstract supplies no detailed results by coffee type, so it does not establish a preferred type or explain why associations differed across disease stages.
The original publication
Coffee Consumption and Colorectal Cancer Survival: A Dose-Response Meta-analysis by Coffee Type and Disease Stage.
Kim JY, Choi YJ, Ahn YC et al.
Cancer Epidemiol Biomarkers Prev · 2026
- PubMed ID
- 41416862
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.